hepatocellular cancer
Showing 1 - 25 of >10,000
Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))
Recruiting
- Hepatocellular Cancer
- Sorafenib (SOR)
- Hydroxychloroquine (HCQ)
-
San Antonio, TexasUniversity of Texas Health Cancer Center
Sep 16, 2022
Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)
Active, not recruiting
- Carcinoma, Hepatocellular
- +3 more
- Microwave ablation
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 23, 2023
Hepatocellular Cancer Trial in Shanghai (Anlotinib;Toripalimab)
Recruiting
- Hepatocellular Cancer
-
Shanghai, Shanghai, ChinaEastern hepatobilliary surgery hospital
Jul 7, 2022
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
- Atezolizumab plus bevacizumab
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 7, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral
Completed
- Hepatocellular Carcinoma
- +4 more
- nivolumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)
Completed
- Hepatocellular Cancer
- IRM with a 5-minute- additional sequence to measure FRM
-
Clichy, FranceValérie Vilgrain
Jun 20, 2022
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Cyclophosphamide
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,
Not yet recruiting
- Resectable Hepatocellular Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 18, 2023
Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,
Recruiting
- Hepatocellular Cancer
- +2 more
- durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Vascular Invasion Signatures in cfDNA Support Re-staging of
Completed
- Carcinoma, Hepatocellular
- +2 more
- Liver resection
-
Shanghai, Shanghai, ChinaEastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022
Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Durvalumab
- +5 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Liver Tumors Trial in Zhongshan (Biomarker testing and Ultrasonography)
Active, not recruiting
- Liver Neoplasms
- Biomarker testing and Ultrasonography
-
Zhongshan, Guangdong, ChinaZhongshan People's Hospital
Apr 23, 2022
Hepatocellular Cancer, Microwave Ablation, Microwave Thermosphere Ablation Trial (True circular microwave needle)
Recruiting
- Hepatocellular Cancer
- +3 more
- True circular microwave needle
-
Tianjin, Tianjin, ChinaTianjin Third Central Hospital
Dec 11, 2022
Carcinoma, Hepatocellular Trial in Navi Mumbai (radiation, procedure, drug)
Recruiting
- Carcinoma, Hepatocellular
- SBRT
- +2 more
-
Navi Mumbai, Maharashtra, India
- +1 more
Apr 25, 2022
Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase
Not yet recruiting
- Hepatocellular Carcinoma
- +6 more
- OTX-2002
- +3 more
-
San Antonio, TexasNext Oncology
Aug 9, 2022
Recurrent Hepatocellular Cancer, Chronic Liver Disease and Cirrhosis Trial in Seoul (Radiofrequency ablation using combined
Recruiting
- Recurrent Hepatocellular Cancer
- Chronic Liver Disease and Cirrhosis
- Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 10, 2022
Hepatocellular Cancer Trial in Phoenix, Chicago, Winston-Salem (device, drug, other)
Recruiting
- Hepatocellular Cancer
- TheraBionic Device
- +2 more
-
Tampa, Florida
- +6 more
Dec 12, 2022
Stage III Hepatocellular Cancer (CNLC Staging) Trial in Guangzhou (mFOLFOX7+Camrelizumab+Apatinib)
Recruiting
- Stage III Hepatocellular Cancer (CNLC Staging)
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 6, 2022
Hepatocellular Cancer, Liver Cirrhoses, Diagnoses Disease Trial in Tianjin (Diagnostic Sonazoid-CEUS and EOB-MRI)
Recruiting
- Hepatocellular Cancer
- +2 more
- Diagnostic Sonazoid-CEUS and EOB-MRI
-
Tianjin, Tianjin, ChinaTianjin Third Central Hospital
Dec 11, 2022
Blood, Urine, and Bone Marrow
Recruiting
- Non Small Cell Lung Cancer
- +5 more
- Test for circulating tumor cells, DNA alterations
-
Columbia, MissouriHarry S Truman Veterans Memorial Hospital
Oct 31, 2022
Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)
Not yet recruiting
- Esophageal Cancer
- +3 more
- Q702
- Pembrolizumab
- (no location specified)
Jun 27, 2022
Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,
Active, not recruiting
- Recurrent Hepatocellular Carcinoma
- +4 more
- Cyclophosphamide
- +2 more
-
Scottsdale, Arizona
- +2 more
Oct 7, 2022
Recurrent Hepatocellular Cancer Trial (toripalimab, Lenvatinib, Radiofrequency ablation)
Not yet recruiting
- Recurrent Hepatocellular Cancer
- toripalimab
- +2 more
- (no location specified)
Jan 12, 2022